Ozempic and other weight loss drugs aren't lowering health care costs yet
GLP-1 drugs like Wegovy (NVO) might help with weight loss, but they aren’t leading to lower health care costs yet, according to a new analysis of U.S. health insurance claims.
Weight-loss drugs didn't curb health costs within two years
Drugs like Wegovy may trim your waistline but not medical costs, according to an analysis of U.S. health insurance claims shared with Reuters.
Use of Weight Loss Drug Widespread, and Costly
As obesity rates in the United States soar, insurance companies, including Medicaid and Medicare, are facing financial headwinds to pay for prescription drugs for weight loss. Semaglutide, the generic name for Mounjaro,
Popular weight loss drugs could help with alcohol, opioid addictions: study
A new study suggests weight loss drugs like Ozempic and Mounjaro could provide a promising new treatment for substance use disorders.
Ozempic: Weight Loss Drug May Help With Addiction Too
These medications have been associated with a 40 percent reduction in opioid overdose and 50 percent lower rate of alcohol intoxication.
Opinion
New weight loss drugs raise questions of access, costs
New, popular injectable weight loss drugs — GLP-1 drugs — are highly effective at reducing obesity and, probably, the health risks posed by obesity. Yet the drugs are so expensive that insurers are often choosing between two bad options: restricting access or raising consumer costs.
Healthy Returns: Weight loss, diabetes drugs may reduce alcohol and opioid use
GLP-1 drugs such as Novo Nordisk’s Ozempic can cut drug and alcohol abuse by around half. Meanwhile, tech companies are talking the future of AI in health care.
People on the street: Weight-loss drugs
With drugs like Ozempic having recently entered the public mind, and seemingly having a hugely positive impact on people’s lives. There has been talk of obese and overweight people being prescribed Ozempic in order to get them back into the workforce.
Lilly's weight loss drug shortage deemed over, but hurdles remain
Some patients fear tirzepatide, sold by Eli Lilly under the brand names Zepbound and Mounjaro, will be hard to get and ...
Shady drugmaker used code words to sell knockoff weight-loss drug: Lawsuit
Amid ongoing legal battles over coveted GLP-1 therapies, a drug vendor in Washington state is accused of running an ...
The Reporter7d
Best Weight Loss Pills Over The Counter: Top Options for 2024 Revealed
If you’re looking to shed those extra pounds, over-the-counter weight loss pills can offer a convenient and accessible solution. These supplements, available without a prescription, are designed ...
Healthline3d
How Ozempic, GLP-1 Weight Loss Drugs Affect the Brain to Curb Substance Misuse
A recent study found significant reductions in opioid overdose and alcohol misuse among people taking GLP-1 drugs like ...
US Medicaid programs say cost a key factor for weight-loss drug coverage, survey finds
Most U.S. states do not currently cover highly sought after weight-loss drugs from Novo Nordisk and Eli Lilly in their ...
STAT2d
More state Medicaid programs consider covering GLP-1 drugs
While all state Medicaid programs cover GLP-1 agonists for type 2 diabetes, it’s much less common for them to cover the drugs ...